- Home
- VLN vs CLYM Comparison
VLN vs CLYM Comparison
Compare VLN & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLN
- CLYM
- Stock Information
- Founded
- VLN 2006
- CLYM 2018
- Country
- VLN Israel
- CLYM United States
- Employees
- VLN N/A
- CLYM N/A
- Industry
- VLN Semiconductors
- CLYM
- Sector
- VLN Technology
- CLYM
- Exchange
- VLN Nasdaq
- CLYM NYSE
- Market Cap
- VLN 208.5M
- CLYM 201.7M
- IPO Year
- VLN N/A
- CLYM 2021
- Fundamental
- Price
- VLN $3.20
- CLYM $1.82
- Analyst Decision
- VLN Strong Buy
- CLYM
- Analyst Count
- VLN 1
- CLYM 0
- Target Price
- VLN $4.00
- CLYM N/A
- AVG Volume (30 Days)
- VLN 1.0M
- CLYM 668.0K
- Earning Date
- VLN 02-26-2025
- CLYM 11-12-2024
- Dividend Yield
- VLN N/A
- CLYM N/A
- EPS Growth
- VLN N/A
- CLYM N/A
- EPS
- VLN N/A
- CLYM N/A
- Revenue
- VLN $63,134,000.00
- CLYM N/A
- Revenue This Year
- VLN N/A
- CLYM N/A
- Revenue Next Year
- VLN $28.12
- CLYM N/A
- P/E Ratio
- VLN N/A
- CLYM N/A
- Revenue Growth
- VLN N/A
- CLYM N/A
- 52 Week Low
- VLN $1.67
- CLYM $1.73
- 52 Week High
- VLN $3.50
- CLYM $11.55
- Technical
- Relative Strength Index (RSI)
- VLN 69.88
- CLYM N/A
- Support Level
- VLN $3.22
- CLYM N/A
- Resistance Level
- VLN $3.50
- CLYM N/A
- Average True Range (ATR)
- VLN 0.23
- CLYM 0.00
- MACD
- VLN 0.03
- CLYM 0.00
- Stochastic Oscillator
- VLN 80.00
- CLYM 0.00
About VLN Valens Semiconductor Ltd.
Valens Semiconductor Ltd is a provider of semiconductor products, pushing the boundaries of connectivity by enabling long-reach, high-speed video, and data transmission for the audio-video and automotive industries. It operates in two segments: Audio-Video, which includes the company's HDBaseT solutions for the Audio-Video market deliver superior, plug-and-play convergence and distribution of different interfaces, through a single long-distance category cable; and Automotive segment products enable safe and resilient high-speed in-vehicle connectivity for car architectures, realizing the vision of connected and autonomous cars. The company's geographical revenue is derived from Hungary.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.